Gabrielle Sulzberger Eli Lilly & CO (LLY) insider trading activity

Gabrielle Sulzberger is Director of ELI LILLY & Co. Currently has a direct ownership of 2,710 shares of LLY, which is worth approximately $2.03 Million. The most recent transaction as insider was on Aug 21, 2023, when has been sold 9 shares (Common Stock) at a price of $550.5 per share, resulting in proceeds of $4,954. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.71K

5.08% 3M change

23.74% 12M change

Total Value Held $2.03 Million

Gabrielle Sulzberger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 21 2023	BUY Grant, award, or other acquisition	$4,954 $550.5 p/Share	9 Added 0.53%	1,694 Common Stock
Jul 17 2023	BUY Grant, award, or other acquisition	$4,918 $447.14 p/Share	11 Added 0.65%	1,685 Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	$4,971 $451.95 p/Share	11 Added 0.65%	1,674 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$4,779 $434.51 p/Share	11 Added 0.66%	1,659 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	$4,840 $372.35 p/Share	13 Added 0.78%	1,648 Common Stock
Mar 20 2023	BUY Grant, award, or other acquisition	$5,004 $333.6 p/Share	15 Added 0.91%	1,635 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	$4,912 $327.51 p/Share	15 Added 0.92%	1,614 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	$5,008 $357.74 p/Share	14 Added 0.87%	1,599 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	$10,017 $357.78 p/Share	28 Added 1.74%	1,585 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	$189,614 $361.17 p/Share	525 Added 25.25%	1,554 Common Stock
Oct 17 2022	BUY Grant, award, or other acquisition	$9,983 $332.76 p/Share	30 Added 2.83%	1,029 Common Stock
Sep 19 2022	BUY Grant, award, or other acquisition	$10,068 $305.09 p/Share	33 Added 3.2%	999 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	$10,046 $313.94 p/Share	32 Added 3.22%	963 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	$9,975 $321.77 p/Share	31 Added 3.22%	931 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	$9,812 $297.34 p/Share	33 Added 3.54%	900 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	$9,880 $299.38 p/Share	33 Added 3.68%	864 Common Stock
Apr 18 2022	BUY Grant, award, or other acquisition	$9,861 $298.82 p/Share	33 Added 3.82%	831 Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	$9,848 $289.64 p/Share	34 Added 4.09%	798 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	$9,804 $239.13 p/Share	41 Added 5.11%	761 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	$9,883 $247.07 p/Share	40 Added 5.26%	720 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$174,957 $258.43 p/Share	677 Added 50.0%	677 Common Stock

Also insider at

Mastercard Inc Financial Services

Director

BRX

Brixmor Property Group Inc. Real Estate

Director

CERE

Cerevel Therapeutics Holdings, Inc. Healthcare

WRBY

Warby Parker Inc. Healthcare

Director